Emily Kaiser Maharjan, Assistant Managing Editor

MIEBO, previously known as NOV03, is the first and only FDA-approved treatment for dry eye disease that targets tear evaporation.

Today, Alimera Sciences announced that they have acquired the US commercial rights of Yutiq (fluocinolone acetonide intravitreal insert) 0.18mg for the treatment of chronic non-infectious uveitis. Yutiq now joins Iluvien (fluocinolone acetonide intravitreal insert) 0.19 mg for DME in Alimera’s retina portfolio.

The DR:EAM study in investigating novel eye drop OTT-166 for the treatment of diabetic retinopathy in hopes of reducing treatment burden for patients.

Xiongfei Liu, MD, is presenting a talk entitled, "Effectiveness and safety of combining 2 MIGS devices in patients with open angle glaucoma," at ASCRS 2023 in San Diego, California.

The medical technology company ViaLase will reveal the 2-year data from their FLigHT clinical study as well as give additional information about their pipeline at ASCRS 2023.

Robert Maloney, MD, shares a sneak peek of his presentation and what he's looking forward to during the symposium.

Jill Saxon, OD, returns to Optometry Times On Air to discuss industry achievements, including the launch of the Women's Leadership Network and the Military Network at Bausch + Lomb.

The aspheric, monofocal, single-piece C-loop IOL from Zeiss compensates for a range of spherical aberrations to minimize decentration and lens misalignments.

Jamie Kuzniar, OD, discusses scleral lens fitting for patients with keratoconus at the IKA Keratoconus Symposium in Scottsdale, Arizona.

Positive 42-month Cypress axial length and cSER outcomes, presented at ARVO in New Orleans, reinforce myopia control safety and efficacy of Diffusion Optics Technology™ spectacle lenses.

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.

Today at the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.

President and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.

Co-founder of the International Keratoconus Academy S. Barry Eiden, OD, FAAO, FSLS, gives us the inside scoop on the inaugural IKA Keratoconus Symposium, which takes place this weekend in Scottsdale, Arizona.

Women head 42% of schools of optometry.

Jill Saxon, OD, executive director of professional strategy at Bausch + Lomb, shares the story of her career and the highlights of working within the industry.

Euin Cheong, OD, weighs in on the Syfvore approval for geographic atrophy and how optometrists should participate in geographic atrophy care.

Jennifer Tsai, OD, tells us how to start the conversation with patients about dual-wear, and the benefits of this from the patient and provider perspective.

Mitch Ibach, OD, FAOO, tells us about the current corneal cross-linking treatments, as well as those on the horizon.

On World Optometry Day 2023, we asked experts to share what this industry means to them.

Following the enrollment completion for Brimochol PF, topline Phase 3 data for the presbyopia candidate is expected in Q2 2023.

Catch up on what to expect from Lumenis.

Mohammad Rafieetary, OD, shares key highlights from his VEE 2023 presentation looking at what's hot in retina.

Vision Expo East 2023 will take place in New York, New York, on March 16-19 at the Javits Center.

To maintain brand recognition, Optical Lab Software and Solutions is now Rx-Universe’s brand statement, which clearly communicates what the organization offers.

Paul Chous, MA, OD, FAAO, shares key highlights from his 2023 SECO presentation looking at sleep disorders and how they play a role in eye disease.

In Atlanta, Georgia, the OIS @ SECO Innovation Showcase highlighted the best and the brightest optometric and ophthalmic drugs, therapies, and tech we hope to see come to fruition.

Andy Lee, MD, gives highlights from his SECO special session, "Neuro nuggets."

Nate Lighthizer, OD, gives highlights from his SECO 2023 presentation, "The glaucoma compass."

Tarsus has received a PDUFA date for their TP-03 drug, which they are hoping to bring to market later this year.